Lipocine (LPCN) Reports Q1 Loss, Beats Revenue Estimates

Lipocine (LPCN) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to a loss of $0.35 per share a year ago.